In an interview with Targeted Oncology, Katy Rezvani, MD, PhD, vice president and head, Institute for Cell Therapy Innovation and Discovery, Department of Institute for Cell Therapy Innovation and Discovery, Division of Cancer Medicine, The…
Using Genome Screening to Improve CAR-NK Cell Therapy | Targeted Oncology
